Granulosa cell mitogenesis is critical for the development of normal ovarian follicles. FSH and other mitogenic stimuli play a crucial role in this process. We have shown that exposing granulosa cells to 5␣-dihydrotestosterone (DHT) reduces forskolin-stimulated cyclin D2 mRNA expression, which leads to cell cycle arrest resulting in reduced cell proliferation. The present study investigated the signaling molecules upstream of cyclin D2 in FSH-mediated, cAMP-dependent signaling pathway that may be negatively affected by DHT, leading to inhibition of cell cycle progression. Because ERK is an important molecule in mitogenic signaling, the possible effect of DHT on its phosphorylation was examined. Granulosa cells from 3-d estradiol-primed immature rats were treated with DHT (90 ng/ml) for 24 h and subsequently stimulated with There are several reports in the literature showing the inhibitory effect of androgens on ovarian follicular function. For example, FSH-mediated induction of LH receptors (10) has been shown to be blocked by androgens in granulosa cells (11, 12) . Some of the earlier studies implicated 5␣-reduced metabolites of androgens for this deleterious effect (13-15). Administration of dihydrotestosterone (DHT), a 5␣-reduced metabolite of testosterone, has been shown to reduce ovulation in rats (16). More recently, we have demonstrated that DHT inhibits granulosa cell proliferation by reducing the cyclin D2 mRNA expression and arrests cell cycle progression at the G1/S interphase (17).
. The growing follicle consists of an oocyte surrounded by a single layer of granulosa cells. An increase in the rate of cell proliferation in response to mitogenic stimuli results in the formation of the large preovulatory follicle with many layers of granulosa cells and outer layers of thecal cell (1) (2) (3) (4) . Thecal cells synthesize androgens, and these androgens are aromatized into estrogens in granulosa cells (5) (6) (7) . Estrogens have been known to be a positive regulator of follicular growth by enhancing the response to FSH and other mitogenic stimuli (8) . Elevated levels of androgens, however, impair follicular function, resulting in anovulation as evidenced in certain pathophysiological conditions (9) .
There are several reports in the literature showing the inhibitory effect of androgens on ovarian follicular function. For example, FSH-mediated induction of LH receptors (10) has been shown to be blocked by androgens in granulosa cells (11, 12) . Some of the earlier studies implicated 5␣-reduced metabolites of androgens for this deleterious effect (13) (14) (15) . Administration of dihydrotestosterone (DHT), a 5␣-reduced metabolite of testosterone, has been shown to reduce ovulation in rats (16) . More recently, we have demonstrated that DHT inhibits granulosa cell proliferation by reducing the cyclin D2 mRNA expression and arrests cell cycle progression at the G1/S interphase (17) .
Although the 5␣-reduced metabolites of androgens are known to antagonize FSH action, the site at which DHT blocks the FSH signaling pathway is not understood. In this study, we have examined the effect of DHT in the FSH-and cAMP-dependent signaling pathway, which leads to cyclin D2 mRNA expression in rat granulosa cells. The ability of growth factors to stimulate cell proliferation requires ERK (or MAPK) (18) . FSH has been known to activate ERK through a cAMP-dependent signaling pathway in granulosa cells (19, 20) . The mammalian ERK family includes ERK-1 and ERK-2 (MAPK-1 and MAPK-2), p38 MAPK, c-Jun N-terminal kinase and stress-activated protein kinases, ERK-3, ERK-4, ERK-5, and ERK-7. Among these kinases, ERK-1 and ERK-2 are the most commonly activated kinases in signal transduction during mitogenesis (21) .
Because FSH has been shown to act through the cAMPdependent protein kinase (PKA)-dependent signaling pathway leading to the activation of MAPK (19, 20) , we examined these steps as possible targets of DHT action. The present study examines the effects of DHT treatment on PKA activity and ERK-2 phosphorylation. We show that DHT causes a reduction in forskolin and FSH-stimulated ERK-2 activation. Reduced ERK activation, in turn, leads to reduced cyclin D2 mRNA expression. Thus, the present study shows that DHT reduces cyclin D2 mRNA expression by inhibiting ERK activation. 
Materials and Methods Materials

Animals and treatments
Twenty-two-day-old female Sprague Dawley rats (Harlan) were housed in a temperature-controlled room with proper dark-light cycles and were under the care of the University of Michigan Unit of Laboratory Animal Medicine. The animals were primed with estradiol (1.5 mg/d) for 3 d to stimulate the development of large preantral follicles (22) and killed 24 h after the last estradiol administration by CO 2 asphyxiation, and their ovaries were collected. Granulosa cells were harvested and cultured in DMEM-F12 medium containing 90 ng/ml DHT or vehicle alone for 24 h.
Granulosa cell isolation and culture
Granulosa cells were isolated as previously described (17, 23) . In brief, the ovaries were cleared from the surrounding fat and punctured with 27-gauge needles. Cells were collected in phenol red-free DMEM-F12 containing 0.2% BSA, 10 mm HEPES, and 6.8 mm EGTA, incubated for 15 min at 37 C under 95% O 2 -5% CO 2 , and centrifuged for 5 min at 250 ϫ g. The pellets were suspended in a solution containing 0.5 m sucrose, 0.2% BSA, and 1.8 mm EGTA in DMEM-F12 and incubated for 5 min. After the incubation, the suspension was diluted with 3 vol DMEM-F12, centrifuged for 5 min at 250 ϫ g, and treated sequentially with trypsin (20 g/ml) for 1 min, 300 g/ml soybean trypsin inhibitor for 6 min, and deoxyribonuclease (DNAse I) (100 g/ml) for 6 min at 37 C to remove dead cells. The cells were then rinsed twice with serum-free media and suspended in DMEM-F12, and cell number was determined. Cell viability was examined by the trypan blue exclusion technique, and the cells were cultured in serum-free DMEM-F12 supplemented with 20 mm HEPES (pH 7.4), 4 mm glutamine, 100 IU penicillin/ml, and 100 g/ml streptomycin. Before plating, the culture dishes were coated with 10% fetal calf serum for 2 h at 37 C and washed with DMEM-F12.
cAMP assay
After a 24-h incubation with DHT (90 ng/ml), cells were treated with 0.5 mm of IBMX for 15 min and, thereafter, stimulated with forskolin (10 m) when indicated. The reaction was stopped by removing the media, and cells were washed with PBS. Cells were harvested using PBS-EDTA, pelleted by centrifugation at 2500 ϫ g for 8 min at 4 C, and dissolved in 100% ethanol. After 21 h, ethanol was evaporated under vacuum. cAMP production was measured using the Biotrak cAMP [
125 I] assay system (Amersham Pharmacia Biotech) according to the manufacturer's instructions.
Western blot analysis
Granulosa cells, after 24 h of exposure to DHT (90 ng/ml) or vehicle, were stimulated with forskolin (10 m) or ovine FSH (50 ng/ml) as indicated for each experiment. The cells were washed with PBS, lysed in modified radioimmunoprecipitation assay buffer (RIPA), and subjected to SDS-PAGE. Western blot analysis for phosphorylated ERK-2 was performed with specific antibody against phosphorylated form of ERK-2. Protein loading was normalized by reprobing the same blot with antibody against nonphosphorylated form of the ERK-2. The PKA protein level was examined by Western blot analysis using an antibody against PKA catalytic subunit ␣. The protein loading was normalized on the basis of tubulin. Detection was performed with an enhanced chemiluminescence Western blotting detection system (ECL; Amersham Pharmacia Biotech). The signals were measured using an Arcus II scanner (Agfa, Wilmington, MA) and quantitated using the NIH Image 1.61 program (Bethesda, MD).
Inhibition of ERK pathway
The inhibitor U0126 (1,4,-diamino-2,3-dicyano-1,4-bis [2-aminophenylthio] butadiene) was used to block ERK phosphorylation as previously described (24) . Briefly, granulosa cells after overnight attachment were incubated with vehicle or U0126 (10 m) for 15 min followed by forskolin (10 m) stimulation for 5 min. The cells were then lysed, and Western blot analysis was performed for phosphorylated ERK-2. The blot was stripped and reprobed for total ERK-2 to normalize for protein loading.
PKA activity assay
PKA activity was assayed by measuring the transfer of 32 P from ␥ [ 32 P] ATP to Kemptide, a protein kinase substrate, as reported previously, with some modifications (25) . In brief, granulosa cells from 3-d estradiol-primed rats were incubated with 90 ng/ml DHT or vehicle. After 24 h of incubation, media was removed, and cells were washed once with PBS. Cells were then harvested in ice-cold phosphate buffer (pH 7.4) [10 mm NaHPO 4 , 1 mm EDTA, 1 mm dithiothreitol, and 250 mm sucrose containing 0.2 mm phenylmethylsulfonylfluoride and leupeptin (10 g/ml)] and homogenized. The homogenate was centrifuged at 14000 ϫ g for 5 min at 4 C, and supernatant was collected. Ten microliters of the supernatant were then added to a 40-l reaction mixture containing 30 m Kemptide, 20 mm Tris-HCl (pH 7.4), 10 mm magnesium acetate, 0.5 mm IBMX, 10 mm dithiothreitol, 5 mm NaF, and 200 m ␥ [ 32 P] ATP (200 cpm/pmol), in the absence or presence of 5 m exogenous cAMP, and incubated at 30 C for 0, 3, and 5 min. At the end of the incubation period, 10 l of the reaction mixture was spotted onto Whatman ion exchange cellulose filter papers (P81) and washed three times with 75 mm phosphoric acid and once with 95% ethanol. Filter papers were then dried under a heat lamp and placed in vials, and radioactivity was determined after the addition of scintillation fluid using a liquid scintillation counter.
Northern blot analysis of cyclin D2
Granulosa cells from 3-d estradiol-primed rats were harvested. After overnight attachment, one group of cultures was treated with DHT (90 ng/ml) for 24 h followed by FSH (50 ng/ml) for 2 h. In experiments in which the effect of MAPK kinase inhibitor (U0126) on FSH-stimulated cyclin D2 mRNA expression was tested, one group of cultures was pretreated with the inhibitor (10 m) for 15 min, and a second group was pretreated with vehicle. After 15 min, one group of cultures from both control and inhibitor-treated cells was incubated with FSH (50 ng/ml) for 2 h. At the end of the incubation with FSH, the medium was decanted, and cells were washed once with PBS; the cells were harvested, and total RNA was extracted using TRIzol reagent according to the manufacturer's instructions (Life Technologies Inc.). The cyclin D2 cDNA (1.1 kb) probe was radiolabeled using [␣ 32 P] deoxy-CTP and the RTS RadPrime DNA labeling system and was hybridized to blots overnight at 42 C using a 2 ϫ 10 7 cpm-labeled probe. The hybridized blots were washed and exposed at Ϫ70 C to XAR film (Eastman Kodak Co., Rochester, NY). The films were developed, and the signals were measured using the National Institutes of Health Image 1.61 program. Blots were stripped and rehybridized with a radiolabeled cDNA probe corresponding to 18S rRNA to monitor total RNA loading.
Statistical analysis
Statistical analysis was carried out using the unpaired t test using Sigma Stat computer software (version 2.0; SPSS Inc., Chicago, IL). Each experiment was repeated at least three times with similar results. Blots are representative of one experiment, and graphs represent the mean Ϯ se of three experiments.
Results
Effect of DHT on forskolin-mediated stimulation of ERK-2 phosphorylation
Recent studies have shown that FSH signaling pathway involves ERK activation in granulosa cells (19) . Forskolin, a diterpene, mimics the actions of FSH by increasing intracellular levels of cAMP (19, 26, 27) . Therefore, we first tested whether DHT had any effect on forskolin-mediated activation of ERK. The results of Western blot analysis showed that control cells stimulated with forskolin for 5 min produced a significant increase (P Ͻ 0.05) in ERK-2 phosphorylation (Fig. 1A) , whereas DHT treatment significantly reduced (P Ͻ 0.05) this stimulation (Fig. 1C) . The antibody used in this experiment specifically recognizes the phosphorylated (activated) form of ERK-2. The total ERK-2 protein remained identical in all experimental groups (Fig. 1B) , suggesting that forskolin induces the phosphorylation of ERK-2. DHT specifically inhibited forskolin-mediated induction of ERK-2 phosphorylation.
Effect of DHT on forskolin-stimulated cAMP production
Because forskolin mimics the action of FSH to increase cAMP production, the effect of DHT on forskolin-stimulated cAMP accumulation was tested in granulosa cells. Control and DHTtreated granulosa cells were stimulated with forskolin for 0, 3, and 5 min, and cAMP production was measured. Figure 2 shows that both control and DHT-treated cells responded to forskolin stimulation with increased cAMP production without any significant difference at all time points tested. Basal levels of cAMP also did not show any significant difference between the control and DHT-treated groups. These results clearly show that DHT treatment exerts its inhibitory effect on ERK-2 phosphorylation without affecting the responsiveness of forskolin for cAMP production. 
Effect of DHT on PKA activity
The actions of FSH are mediated through the increase in cAMP level and subsequent activation of PKA (28 -30) . Furthermore, it has also been demonstrated that FSH up-regulates ERK through activation of PKA in granulosa cells, and this action is mediated by cAMP (19, 20) . Therefore, we examined whether DHT treatment exerts any effect on PKA activity. When the protein kinase activity of control and DHT-treated granulosa cells was compared in the presence or absence of exogenous cAMP, cells from DHT-treated groups showed significantly lower PKA activity than controls (Figs. 3 and 4) . However, both control and DHT-treated cells expressed the same level of PKA catalytic subunit ␣ protein (Fig. 5) , indicating that the reduction in PKA activity in response to DHT treatment is not due to decreased protein level.
DHT reduces the FSH-stimulated ERK-2 phosphorylation
Because the above experiments clearly showed that DHT reduces forskolin-mediated ERK-2 phosphorylation by decreasing the PKA activity, we next tested the effects of DHT on ERK activation in response to FSH treatment. Cells were incubated in the presence or absence of DHT (90 ng/ml) for 24 h and then stimulated with or without FSH (50 ng/ml) for 5 min. Control cells stimulated with FSH showed significantly increased (P Ͻ 0.05) phosphorylation of ERK-2 (Fig.  6A) , and DHT significantly reduced (P Ͻ 0.05) this stimulation (Fig. 6C) , which was similar to the inhibition seen in forskolin-treated cells. Total ERK2 protein expression did not show any change during this time period (Fig. 6B) .
Inhibition of ERK-2 phosphorylation decreases cyclin D2 mRNA expression
After establishing that DHT reduces FSH-mediated ERK-2 phosphorylation, further studies were carried out to determine whether reduction in ERK phosphorylation leads to a reduction in cyclin D2 mRNA expression. To test this, the ERK pathway was inhibited by a specific inhibitor, U0126. Treating the cells with 10 m of U0126 for 15 min significantly inhibited (P Ͻ 0.05) forskolin-mediated ERK-2 phosphorylation (Fig. 7C) , confirming its known inhibitory effect (Fig.  7A) . Total ERK protein expression did not show any change (Fig. 7B) . We next tested the effect of blocking ERK pathway by U0126 on cyclin D2 mRNA expression. Granulosa cells were pretreated with U0126 followed by stimulation with FSH for 2 h. Northern blot analysis showed that, although FSH alone significantly increased (P Ͻ 0.05) cyclin D2 mRNA expression (Fig. 8A) , the inhibition of ERK pathway significantly reduced (P Ͻ 0.05) this stimulation (Fig. 8C) . Total RNA loading did not show any difference (Fig. 8B) . This result shows that inhibition of ERK pathway leads to a reduction in cyclin D2 mRNA expression.
DHT reduces FSH-stimulated cyclin D2 mRNA expression
The results presented in Fig. 9 show that, as expected, DHT treatment inhibited FSH stimulation of cyclin D2 mRNA expression. FSH treatment produced a significant increase (P Ͻ 0.05) in cyclin D2 mRNA expression (Fig. 9A ), whereas pretreatment with DHT for 24 h before FSH addition blunted this response (Fig. 9C) . Thus, the inhibitory effect of DHT on forskolin-stimulated cyclin D2 mRNA expression (17) was also demonstrated on FSH-stimulated response as well.
Discussion
We have previously shown that DHT inhibits the granulosa cell cycle progression from G1 to S phase, thereby reducing cell proliferation (17) . The present study is a follow-up of these earlier observations to determine the effect of DHT on the FSH-mediated signaling pathway, which leads to the reduction in cyclin D2 mRNA expression. In granulosa cells, as in other steroidogenic cells, the binding of FSH to its receptor leads to an increase in the intracellular level of cAMP followed by activation of PKA, culminating in ERK phosphorylation (20) . ERK is a key regulator of cell proliferation because its activation during G1 progression has been implicated for the entry into the S phase of the cell cycle (31, 32) . Transient activation of ERK has been reported to be essential for cell proliferation (33, 34) . The involvement of ERK activation has also been reported in the FSH-mediated proliferation of ovarian epithelial cells (35) . Furthermore, ERK activation has been implicated in an increase in DNA synthesis (36) . Because FSH is shown to activate ERK, we examined whether the inhibitory effect of DHT is exerted at the level of ERK-2 phosphorylation in response to fors- kolin treatment. Our results show that forskolin produced a significant increase (P Ͻ 0.05) in stimulation of ERK-2 phosphorylation within 5 min compared with control ( Fig. 1) , and this stimulatory effect was blunted in DHT-treated cells. These observations suggest that the previously observed inhibition of cell cycle progression by DHT (17) might be due to its inhibitory effect on ERK-2 activity.
Because FSH exerts its effects mainly through the elevation of intracellular cAMP (37, 38) , a potential site for inhibitory effect of DHT could lie at the level of adenyl cyclase. Because we have observed an inhibition in the phosphorylation of ERK in DHT-treated cells, we suspected that a similar inhibition might also occur on cAMP production. However, forskolin stimulated cAMP production in both control and DHT-treated cells without any significant difference between them (Fig. 2) . This result shows that DHT does not affect adenylate cyclase activity in rat granulosa cells and that its inhibitory effect on ERK-2 lies at a step after the cAMP production. It has already been established that, in the ovarian tissue, gonadotropin stimulation increases the cAMP accumulation and the activation of PKA, leading to increased steroidogenesis (39 -41) . Although DHT did not inhibit the cAMP levels, it significantly reduced the PKA activity both in the absence and presence of exogenous cAMP (Figs. 3 and  4) . Because both DHT-treated and control cells expressed similar levels of PKA protein (Fig. 5) , it is clear that the reduced activity seen in response to DHT is not due to reduced PKA protein expression in the cells. The mechanism by which DHT inhibits PKA activity is not currently known.
In the present study, we have shown that the inhibitory effect of DHT on forskolin-mediated ERK phosphorylation also occurs on FSH-stimulated ERK phosphorylation (Fig. 6) . We have provided evidence to show that DHT inhibition of cyclin D2 mRNA expression is due to its inhibitory effect on ERK phosphorylation. FSH treatment significantly increased (P Ͻ 0.05) ERK phosphorylation as well as cyclin D2 mRNA expression in granulosa cells (Figs. 6 and 8 ). The inhibition of ERK phosphorylation by U0126 led to a reduction in FSH-stimulated cyclin D2 mRNA expression (Fig. 8) . We have also shown that DHT pretreatment causes a similar inhibition of FSH-stimulated cyclin D2 mRNA expression (Fig. 9) . From these results, it is apparent that DHT-mediated reduction of cyclin D2 mRNA expression occurs, at least partially, through the inhibition of ERK activation. Although U0126 pretreatment caused nearly complete inhibition of ERK2 phosphorylation, this inhibitor evoked only partial inhibition of FSH-stimulated cyclin D2 mRNA expression. A probable reason for this difference could be that ERK signaling may be only one arm of FSH signaling that culminates in the stimulation of cyclin D2 expression. Recent reports suggest that FSH can also activate pathways other than the classical cAMP-mediated PKA-dependent pathway. For example, FSH is known to activate Akt kinase or protein kinase B (Akt/PKB) through the phosphatidylinositol 3-kinase kinase pathway independent of PKA (42) . However, the present study clearly shows that cyclin D2 is one of the downstream targets of ERK signaling and that DHT inhibits both forskolin- (17) and FSH-mediated cyclin D2 mRNA expression by blocking, at least partially, signaling through the ERK pathway.
Taken together, our studies show that the inhibition of ERK activation by DHT reduces FSH-stimulated cyclin D2 mRNA expression in granulosa cells. The cell cycle arrest and reduced proliferation of DHT-exposed granulosa cells, as previously reported (17), might be the result of reduced ERK activation. We have also shown for the first time that cyclin D2 expression in rat granulosa cells is sensitive to ERK activation. Furthermore, this inhibitory effect of DHT in FSHstimulated signaling occurs at a post-cAMP level. The mechanism of inhibition of PKA activity by DHT is not understood at the present time. The involvement of other molecules like protein kinase inhibitors in mediating the DHT response or a direct nongenomic action of DHT on the ERK pathway cannot be ruled out at the present time.
FIG. 9. Effect of DHT on FSH-stimulated cyclin D2 mRNA expression in rat granulosa cells. Granulosa cells from 3-d estradiol-primed rats were harvested. After overnight attachment, one group of cultures was incubated with DHT (90 ng/ml) for 24 h, and the other was incubated with vehicle. After the incubation, one set of cultures from both the control and DHT-treated groups was stimulated with FSH (50 ng/ml) for 2 h. A, Total RNA was extracted, and Northern blot analysis was performed using [␣ 32 P] cyclin D2 cDNA probe. B, [␣ 32 P] cDNA for 18S rRNA was used to monitor RNA loading. C, Mean fold increase in cyclin D2 mRNA expression normalized for 18S rRNA when compared with control. Error bar represents Ϯ SEM; a , significant difference (P Ͻ 0.05) when compared with control; b , significant difference (P Ͻ 0.05) when compared with FSH.
